Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mifamurtide

EU orphan designation number: EU/3/16/1700   
Active ingredient: Mifamurtide
Indication: Treatment of hepatocellular carcinoma
Sponsor: Delta Proteomics SAS
6 rue Pierre Haret, 75009 Paris France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/07/2016 Orphan designation EMA/OD/072/16 (2016)4686 of 14/07/2016